{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:37:44Z","timestamp":1793234264026,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.xphs.2019.07.019","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T13:25:30Z","timestamp":1564493130000},"page":"3540-3549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["An Automated and Qualified Platform Method for Site-Specific Succinimide and Deamidation Quantitation Using Low-pH Peptide Mapping"],"prefix":"10.1016","volume":"108","author":[{"given":"Mingyan","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"Kabundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Prophet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei V.","family":"Saveliev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjeta","family":"Urh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.xphs.2019.07.019_bib1","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1021\/bi951526c","article-title":"Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity","volume":"35","author":"Cacia","year":"1996","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.xphs.2019.07.019_bib2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4161\/mabs.24458","article-title":"Comparison of the in\u00a0vitro and in\u00a0vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule","volume":"5","author":"Ouellette","year":"2013","journal-title":"mAbs"},{"issue":"3","key":"10.1016\/j.xphs.2019.07.019_bib3","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/acs.analchem.5b04276","article-title":"LC-MS\/MS-Based monitoring of in\u00a0vivo protein biotransformation: quantitative determination of trastuzumab and its deamidation products in human plasma","volume":"88","author":"Bults","year":"2016","journal-title":"Anal Chem"},{"issue":"6","key":"10.1016\/j.xphs.2019.07.019_bib4","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s11095-007-9241-4","article-title":"Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperatures","volume":"24","author":"Chu","year":"2007","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.xphs.2019.07.019_bib5","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1021\/ac802708s","article-title":"Direct identification and quantification of aspartyl succinimide in an IgG2 mAb by RapiGest assisted digestion","volume":"81","author":"Huang","year":"2009","journal-title":"Anal Chem"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.019_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0003-9861(90)90014-P","article-title":"Formation of cyclic imide-like structures upon the treatment of calmodulin and a calmodulin peptide with heat","volume":"276","author":"Martin","year":"1990","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"10.1016\/j.xphs.2019.07.019_bib7","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1021\/ac702245c","article-title":"Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass spectrometry","volume":"80","author":"Valliere-Douglass","year":"2008","journal-title":"Anal Chem"},{"issue":"7","key":"10.1016\/j.xphs.2019.07.019_bib8","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1021\/ac0617870","article-title":"18O labeling method for identification and quantification of succinimide in proteins","volume":"79","author":"Xiao","year":"2007","journal-title":"Anal Chem"},{"issue":"10","key":"10.1016\/j.xphs.2019.07.019_bib9","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/jps.21655","article-title":"Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain","volume":"98","author":"Yan","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"issue":"15","key":"10.1016\/j.xphs.2019.07.019_bib10","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/ac200750u","article-title":"Accurate determination of succinimide degradation products using high fidelity trypsin digestion peptide map analysis","volume":"83","author":"Yu","year":"2011","journal-title":"Anal Chem"},{"issue":"6","key":"10.1016\/j.xphs.2019.07.019_bib11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5731\/pdajpst.2015.006239","article-title":"Qualification of a quantitative method for monitoring aspartate isomerization of a monoclonal antibody by focused peptide mapping","volume":"70","author":"Cao","year":"2016","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.xphs.2019.07.019_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ab.2018.11.021","article-title":"Characterization and quantification of succinimide using peptide mapping under low-pH conditions and hydrophobic interaction chromatography","volume":"566","author":"Cao","year":"2019","journal-title":"Anal Biochem"},{"issue":"11","key":"10.1016\/j.xphs.2019.07.019_bib13","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/jps.20740","article-title":"Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization","volume":"95","author":"Wakankar","year":"2006","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2019.07.019_bib14","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1021\/bi061500t","article-title":"Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies","volume":"46","author":"Wakankar","year":"2007","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.xphs.2019.07.019_bib15","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1080\/19420862.2018.1511198","article-title":"A\u00a0systematic approach for analysis and characterization of mispairing in bispecific antibodies with asymmetric architecture","volume":"10","author":"Wang","year":"2018","journal-title":"mAbs"},{"issue":"Pt 3","key":"10.1016\/j.xphs.2019.07.019_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/bj3450473","article-title":"Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential","volume":"345","author":"Cloos","year":"2000","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.xphs.2019.07.019_bib17","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/ac0494174","article-title":"In\u00a0vivo deamidation characterization of monoclonal antibody by LC\/MS\/MS","volume":"77","author":"Huang","year":"2005","journal-title":"Anal Chem"},{"issue":"5","key":"10.1016\/j.xphs.2019.07.019_bib18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1023\/A:1018944800691","article-title":"Chemical pathways of peptide degradation. VI. Effect of the primary sequence on the pathways of degradation of aspartyl residues in model hexapeptides","volume":"11","author":"Oliyai","year":"1994","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.xphs.2019.07.019_bib19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1023\/A:1018998312503","article-title":"Chemical pathways of peptide degradation. VII. Solid state chemical instability of an aspartyl residue in a model hexapeptide","volume":"11","author":"Oliyai","year":"1994","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.xphs.2019.07.019_bib20","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/S0021-9258(18)83327-0","article-title":"Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins","volume":"264","author":"Stephenson","year":"1989","journal-title":"J\u00a0Biol Chem"},{"issue":"31","key":"10.1016\/j.xphs.2019.07.019_bib21","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1021\/ja9606182","article-title":"pH-induced change in the rate-determining step for the hydrolysis of the Asp\/Asn-derived cyclic-imide intermediate in protein degradation","volume":"118","author":"Xie","year":"1996","journal-title":"J\u00a0Am Chem Soc"},{"issue":"6","key":"10.1016\/j.xphs.2019.07.019_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1023\/A:1015862026539","article-title":"Chemical pathways of peptide degradation. I. Deamidation of adrenocorticotropic hormone","volume":"7","author":"Bhatt","year":"1990","journal-title":"Pharm Res"},{"issue":"7","key":"10.1016\/j.xphs.2019.07.019_bib23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1023\/A:1015807303766","article-title":"Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide","volume":"7","author":"Patel","year":"1990","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2019.07.019_bib24","doi-asserted-by":"crossref","first-page":"12798","DOI":"10.1038\/ncomms12798","article-title":"Unexpected functional implication of a stable succinimide in the structural stability of Methanocaldococcus jannaschii glutaminase","volume":"7","author":"Kumar","year":"2016","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.xphs.2019.07.019_bib25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s11095-012-0933-z","article-title":"Effect of pH and excipients on structure, dynamics, and long-term stability of a model IgG1 monoclonal antibody upon freeze-drying","volume":"30","author":"Park","year":"2013","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2019.07.019_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-4347(00)00548-X","article-title":"Identification of multiple sources of charge heterogeneity in a recombinant antibody","volume":"752","author":"Harris","year":"2001","journal-title":"J\u00a0Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.xphs.2019.07.019_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2017.03.005","article-title":"Characterization of succinimide stability during trypsin digestion for LC-MS analysis","volume":"526","author":"Nowak","year":"2017","journal-title":"Anal Biochem"},{"issue":"4","key":"10.1016\/j.xphs.2019.07.019_bib28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00726-015-2166-z","article-title":"Mildly acidic conditions eliminate deamidation artifact during proteolysis: digestion with endoprotease Glu-C at pH 4.5","volume":"48","author":"Liu","year":"2016","journal-title":"Amino Acids"},{"issue":"25","key":"10.1016\/j.xphs.2019.07.019_bib29","doi-asserted-by":"crossref","first-page":"19402","DOI":"10.1074\/jbc.M110.120774","article-title":"Repair of isoaspartate formation modulates the interaction of deamidated 4E-BP2 with mTORC1 in brain","volume":"285","author":"Bidinosti","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.019_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/1874609811104010008","article-title":"Damaged proteins bearing L-isoaspartyl residues and aging: a dynamic equilibrium between generation of isomerized forms and repair by PIMT","volume":"4","author":"Desrosiers","year":"2011","journal-title":"Curr Aging Sci"},{"issue":"1","key":"10.1016\/j.xphs.2019.07.019_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/pr060507u","article-title":"Prediction of missed cleavage sites in tryptic peptides Aids protein identification in proteomics","volume":"6","author":"Siepen","year":"2007","journal-title":"J\u00a0Proteome Res"},{"issue":"3","key":"10.1016\/j.xphs.2019.07.019_bib32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/19420862.2019.1578137","article-title":"Charge variants characterization and release assay development for co-formulated antibodies as a combination therapy","volume":"11","author":"Cao","year":"2019","journal-title":"mAbs"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491930485X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491930485X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:26:31Z","timestamp":1758360391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235491930485X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S002235491930485X"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2019.07.019","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Automated and Qualified Platform Method for Site-Specific Succinimide and Deamidation Quantitation Using Low-pH Peptide Mapping","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2019.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}]}}